Vaccine Scheduler

Finland: Recommended vaccinations

	General recommendation
	Recommendation for specific groups only
	Catch-up (e.g. if previous doses missed)
	Vaccination not funded by the National Health system
	Mandatory vaccination

	Birth	Weeks	Months							Years
	Birth	6	2	3	5	6	12	13-15	18	3	4	6	10	12	13	14-15	17	18	25	45	64	65	≥ 66
Coronavirus disease (COVID-19)¹														COVID-19⁴				COVID-19⁵

tuberculosis	BCG⁶

rotavirus infection			ROTA	ROTA	ROTA

diphtheria				D	D		D				D					d			d⁷	d		d⁸
tetanus				TT	TT		TT				TT					TT			TT⁷	TT		TT⁹
pertussis				acP	acP		acP				acP					acp			acp
poliomyelitis				IPV	IPV		IPV				IPV
Haemophilus influenzae type b infection				Hib	Hib		Hib
hepatitis B	HepB¹⁰

pneumococcal disease²				PCV10	PCV10		PCV10											PCV20¹¹

meningococcal disease		MCV4¹²		MCV4/MenB¹³			MCV4/MenB¹⁴	MenB¹⁵

measles							MEAS¹⁶					MEAS
mumps							MUMPS¹⁶					MUMPS
rubella							RUBE¹⁶					RUBE

varicella³									VAR¹⁷			VAR¹⁷

human papillomavirus infection													HPV2 (F/M)¹⁸		HPV2 (F/M)¹⁹

influenza						IIV4/LAIV²⁰																IIV4

tick-borne encephalitis										TBE²¹

Version:

Footnotes:

for updated information refer to https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/koronavirusrokotteet-eli-covid-19-rokotteet-ohjeita-ammattilaisille
for more information on pneumococcal vaccination and target groups refer to https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/pneumokokkirokotteet
Varicella vaccination implemented from 1 September 2017. Catch-up to all those born on 1st January 2006 or after and with no history of varicella.
For high risk groups: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/koronarokotteet/eri-ryhmien-koronarokotukset/vakavan-koronataudin-riskiryhmat
More information: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/koronarokotteet#koronarokotusten-tehosteannokset-ja-niiden-aikataulu
For specific at risk-groups only (to be given at the earliest age)
Thereafter Td booster every 10 years with or without vaccination against poliomyelitis (IPV) in case of travel to endemic areas and when previous IPV dose was given more than 5 years before
Then every 10 years.
Then every 10 years.
risk-groups only (to be given at the earliest age)
for more information on pneumococcal vaccination and target groups refer to https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/pneumokokkirokotteet/riskiryhmien-pneumokokkirokotukset
MCV4: The vaccination series includes a total of two doses, with the second doses been administered at least two months after the first dose. In addition, one booster dose will be given at twelve months of age, no earlier than two months after the second dose of Nimenrix. Nimenrix is administered to children aged six weeks to under two years, while Menveo is recommended for individuals aged two years and older. The number of doses and administration schedule vary depending on the recipient's age. For detailed guidance, please refer to the official information available at: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/meningokokkirokotteet/meningokokki-acwy-rokote
MCV4: The vaccination series includes a total of two doses, with the second doses been administered at least two months after the first dose. In addition, one booster dose will be given at twelve months of age, no earlier than two months after the second dose of Nimenrix. Nimenrix is administered to children aged six weeks to under two years, while Menveo is recommended for individuals aged two years and older. The number of doses and administration schedule vary depending on the recipient's age. For detailed guidance, please refer to the official information available at: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/meningokokkirokotteet/meningokokki-acwy-rokote MenB: Bexsero vaccine is administered to infants aged 2 to 5 months as a series of three doses, spaced at least one month apart. A booster dose is then recommended at 12 to 15 months of age, provided that at least six months have passed since the last dose. The number of doses and administration schedule vary depending on the recipient's age. For detailed guidance, please refer to the official information available at: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/meningokokkirokotteet/meningokokki-b-rokote
Booster doses are administered only under specific circumstances, based on the age at which previous doses were received. Additional information available at: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/meningokokkirokotteet/meningokokki-acwy-rokote AND https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/meningokokkirokotteet/meningokokki-b-rokote
Booster doses are administered only under specific circumstances, based on the age at which previous doses were received. Additional information available at: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/meningokokkirokotteet/meningokokki-acwy-rokote AND https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/meningokokkirokotteet/meningokokki-b-rokote
Recommendation for the first dose to be given at 12 months of age
Further information available at https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/vesirokkorokote
more information available at https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/hpv-eli-papilloomavirusrokote
2 doses under 15 years old and 3 doses from 15 years and older.
more information: https://thl.fi/en/topics/infectious-diseases-and-vaccinations/information-about-vaccinations/vaccination-programme-for-children-and-adults
TBE vaccination for to those living permanently on the island of Åland

More information available at:
https://thl.fi/aiheet/infektiotaudit-ja-rokotukset

--------------------------------------------------------------------------------

MAJOR HISTORICAL CHANGES
1960: Mumps vaccinations for military recruits.
1975: Measles vaccination for 1 year old children.
1975: Rubella vaccination for 11-13 years old girls and seronegative mothers.
1982: Two doses of MMR vaccination at 14-18 months and 6 years of age were introduced in the national childhood vaccination programme.
2009: Rotavirus vaccine introduced at 2, 3 and 5 months to all children (September 2009)
2010: PCV introduced at 3, 5 and 12 months of age to all children (September 2010).
2013: HPV vaccination introduced
2017: Varicella vaccination introduced (1 Sept. 2017) at 18 months, 6 years + catch-up of all born from 1 jan 2006 or after with no history of varicella
2020-21: In school years 2020–2021 and 2021–2022, the vaccine will also be offered to boys in grades 7 to 9 (catch-up vaccinations). The oldest vaccine recipients are those born in 2005.

see https://www.thl.fi/fi/web/rokottaminen/kansallinen-rokotusohjelma/rokotusohjelman-historia

--------------------------------------------------------------------------------

Date of last update: 15 Jan. 2024

--------------------------------------------------------------------------------